The Federal Reserve's 2025 stress test results cleared all 32 large U.S. banks, paving the way for capital return announcements. JPMorgan Chase responded with a $50 billion share repurchase authorization — one of the largest buyback programs in its history — while Goldman Sachs opted to raise its dividend, signaling confidence in its own capital position. Both moves were widely anticipated by the market following the stress test window.

JPMorgan's $50B buyback is notable given its scale: at roughly 4-5% of its current market cap, it represents meaningful EPS accretion if executed over 2-3 years. However, the firm's FY2025 revenue of $193.3B is essentially flat year-over-year (-0.3%), and while net margins of 29.5% remain healthy, there's no organic growth tailwind powering this announcement — it is balance-sheet engineering. Goldman's dividend hike similarly reflects capital adequacy rather than accelerating earnings, with revenue at $80.4B (-1.3% YoY) and net margins at 21.4%.

The second-order setup is whether these capital return programs act as a floor under both stocks or merely delay a re-rating on slowing revenues. For JPM, the buyback shrinks the float and supports EPS even in a flat revenue environment, which is a real mechanical tailwind. For GS, dividend raises tend to attract income-oriented institutional holders and can compress the yield spread vs. peers.

The key watch items are: (1) Q2 earnings execution — do investment banking and trading revenues reaccelerate to validate the capital confidence signal, or does stress-test passage simply confirm survivability rather than growth? (2) The pace of buyback execution at JPM — a $50B authorization is not a commitment to spend it all immediately. Bears will note that both firms are returning capital precisely because organic deployment opportunities are limited in a slowing macro environment.